Delhi High Court Stays Proceedings Against Doctors Initiated Based On Anonymous Pharma Marketing Complaints

The Delhi High Court has granted interim relief to 30 healthcare professionals, including dermatologists, by staying disciplinary proceedings initiated against them. The case originated from an anonymous complaint regarding alleged unethical marketing practices involving pharmaceutical major M/s AbbVie Healthcare India Pvt. Ltd.

The Genesis of the Dispute

The conflict traces back to an anonymous complaint filed on May 21, 2024, alleging that AbbVie Healthcare provided travel tickets and hotel accommodations to doctors under the guise of conferences in Monaco and Paris. These luxury trips allegedly promoted products like Botox and Juvederm. Following an investigation, the Apex Committee for Pharma Marketing Practices directed the National Medical Commission to take action against the involved doctors, leading the Maharashtra Medical Council to issue notices of charge in July 2026.

Arguments and Legal Contentions

The petitioners argued that the entire disciplinary process is legally flawed. They contended that Clauses 10.3 and 10.4 of the Uniform Code of Pharmaceutical Marketing Practices (UCPMP, 2024) strictly mandate that complainants identify themselves, explicitly prohibiting the entertainment of anonymous or pseudonymous complaints. The petitioners further emphasized that Rule 62(3) of the Maharashtra Medical Council Rules, 1967, similarly bars the consideration of such anonymous submissions. They maintained that because the initiation of the process was contrary to governing regulations, all subsequent proceedings, including the notices of charge, were void.

Court’s Legal Analysis

Hon'ble Dr. Justice Swarana Kanta Sharma observed that the core legal question is whether an anonymous complaint can be entertained under the guise of "seriousness of allegations" despite clear statutory prohibitions. The Court noted that the Ethics Committee had initially recognized the issue of maintainability regarding anonymous complaints but the Apex Committee had proceeded regardless.

Highlighting the gravity of the situation, the Court stated: * “The issue as to whether the proceedings which originated from an anonymous complaint could have been entertained on the ground of seriousness of allegations, despite the stipulation contained in Clause 10.4 of the UCPMP, 2024, and whether consequential disciplinary proceedings against the petitioners can be sustained on that basis, requires consideration.” * “The petitioners have made out a case for grant of interim protection.”

Implications of the Ruling

The Delhi High Court’s order effectively halts the disciplinary inquiry currently pending before the Maharashtra Medical Council. By staying the operation of the December 23, 2024, order, the Court has provided temporary relief to the doctors while acknowledging the procedural necessity of adhering to established regulatory frameworks. This decision underscores the importance of procedural compliance in administrative actions, ensuring that regulatory bodies do not bypass mandatory disclosure rules even when faced with serious allegations. The case is set for further hearing on November 26, 2026.